{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:30:41Z","timestamp":1791156641931,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T00:00:00Z","timestamp":1260835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T00:00:00Z","timestamp":1260835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/tpj.2009.59","type":"journal-article","created":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T10:57:01Z","timestamp":1260874621000},"page":"232-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1"],"prefix":"10.1038","volume":"10","author":[{"given":"D","family":"Proudnikov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kroslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Sipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Randesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,15]]},"reference":[{"key":"BFtpj200959_CR1","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990; 87: 1932\u20131936.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj200959_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","volume":"11","author":"M Herkenham","year":"1991","unstructured":"Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC . Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991; 11: 563\u2013583.","journal-title":"J Neurosci"},{"key":"BFtpj200959_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","volume":"83","author":"K Tsou","year":"1998","unstructured":"Tsou K, Brown S, Sa\u00f1udo-Pe\u00f1a MC, Mackie K, Walker JM . Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998; 83: 393\u2013411.","journal-title":"Neuroscience"},{"key":"BFtpj200959_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M . Molecular characterization of peripheral receptor for cannabinoids. Nature 1993; 365: 61\u201365.","journal-title":"Nature"},{"key":"BFtpj200959_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","volume":"310","author":"MD Van Sickle","year":"2005","unstructured":"Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005; 310: 329\u2013332.","journal-title":"Science"},{"key":"BFtpj200959_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002; 54: 161\u2013202.","journal-title":"Pharmacol Rev"},{"key":"BFtpj200959_CR7","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946\u20131949.","journal-title":"Science"},{"key":"BFtpj200959_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215: 89\u201397.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFtpj200959_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1054\/plef.2001.0358","volume":"66","author":"DG Deutsch","year":"2002","unstructured":"Deutsch DG, Ueda N, Yamamoto S . The fatty acid amide hydrolase (FAAH). Prostaglandins Leukot Essent Fatty Acids 2002; 66: 201\u2013210.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"BFtpj200959_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","volume":"74","author":"MK McKinney","year":"2005","unstructured":"McKinney MK, Cravatt BF . Structure and function of fatty acid amide hydrolase. Ann Rev Biochem 2005; 74: 411\u2013432.","journal-title":"Ann Rev Biochem"},{"key":"BFtpj200959_CR11","doi-asserted-by":"publisher","first-page":"9371","DOI":"10.1073\/pnas.161191698","volume":"98","author":"BF Cravatt","year":"2001","unstructured":"Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 2001; 98: 9371\u20139376.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj200959_CR12","doi-asserted-by":"publisher","first-page":"8394","DOI":"10.1073\/pnas.082235799","volume":"99","author":"JC Sipe","year":"2002","unstructured":"Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF . A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci USA 2002; 99: 8394\u20138399.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj200959_CR13","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/hmg\/ddh216","volume":"13","author":"KP Chiang","year":"2004","unstructured":"Chiang KP, Gerber AL, Sipe JC, Cravatt BF . Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 2004; 13: 2113\u20132119.","journal-title":"Hum Mol Genet"},{"key":"BFtpj200959_CR14","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1097\/00001756-199810260-00012","volume":"9","author":"M Navarro","year":"1998","unstructured":"Navarro M, Chowen J, Carrera MRA, del Arco I, Villan\u00faa MA, Martin Y et al. CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. Neuroreport 1998; 9: 3397\u20133402.","journal-title":"Neuroreport"},{"key":"BFtpj200959_CR15","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","volume":"21","author":"M Navarro","year":"2001","unstructured":"Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L et al. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 2001; 21: 5344\u20135350.","journal-title":"J Neurosci"},{"key":"BFtpj200959_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00213-003-1422-1","volume":"168","author":"TJ De Vries","year":"2003","unstructured":"De Vries TJ, Homberg JR, Binnekade R, Raas\u00f8 H, Schoffelmeer AN . Cannabinoid modulation of the reinforcing and motivational properties of heroin-associated cues in rats. Psychopharmacology 2003; 168: 164\u2013169.","journal-title":"Psychopharmacology"},{"key":"BFtpj200959_CR17","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00656-1","volume":"383","author":"MS Mascia","year":"1999","unstructured":"Mascia MS, Obinu MC, Ledent C, Parmentier M, B\u00f6hme GA, Imperato A et al. Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB (1) receptor knockout mice. Eur J Pharmacol 1999; 383: R1\u2013R2.","journal-title":"Eur J Pharmacol"},{"key":"BFtpj200959_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0166-4328(00)00311-9","volume":"118","author":"G Cossu","year":"2001","unstructured":"Cossu G, Ledent C, Fattore L, Imperato A, B\u00f6hme GA, Parmentier M et al. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 2001; 118: 61\u201365.","journal-title":"Behav Brain Res"},{"key":"BFtpj200959_CR19","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1093\/nar\/19.17.4798-a","volume":"19","author":"L Caenazzo","year":"1991","unstructured":"Caenazzo L, Hoehe MR, Hsieh WT, Berrettini WH, Bonner TI, Gershon ES . HindIII identifies a two allele DNA polymorphism of the human cannabinoid receptor gene (CNR). Nucleic Acids Res 1991; 19: 4798.","journal-title":"Nucleic Acids Res"},{"key":"BFtpj200959_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/mcpr.1999.0249","volume":"13","author":"D Gadzicki","year":"1999","unstructured":"Gadzicki D, M\u00fcller-Vahl K, Stuhrmann M . A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Mol Cell Probes 1999; 13: 321\u2013323.","journal-title":"Mol Cell Probes"},{"key":"BFtpj200959_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/sj.mp.4001560","volume":"9","author":"PW Zhang","year":"2004","unstructured":"Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D et al Human cannabinoid receptor 1:5\u2032 exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 2004; 9: 916\u2013931.","journal-title":"Mol Psychiatry"},{"key":"BFtpj200959_CR22","first-page":"880","volume":"3","author":"MR Hoehe","year":"1991","unstructured":"Hoehe MR, Caenazzo L, Martinez MM, Hsieh WT, Modi WS, Gershon ES et al. Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15. New Biol 1991; 3: 880\u2013885.","journal-title":"New Biol"},{"key":"BFtpj200959_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ajmg.1259","volume":"105","author":"SJ Tsai","year":"2001","unstructured":"Tsai SJ, Wang YC, Hong CJ . Association study between cannabinoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders. Am J Med Genet 2001; 105: 219\u2013221.","journal-title":"Am J Med Genet"},{"key":"BFtpj200959_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00041444-200010030-00008","volume":"10","author":"SJ Tsai","year":"2000","unstructured":"Tsai SJ, Wang YC, Hong CJ . Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. Psychiatr Genet 2000; 10: 149\u2013151.","journal-title":"Psychiatr Genet"},{"key":"BFtpj200959_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.mp.4001029","volume":"7","author":"H Ujike","year":"2002","unstructured":"Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M et al. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psychiatry 2002; 7: 515\u2013518.","journal-title":"Mol Psychiatry"},{"key":"BFtpj200959_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neulet.2007.08.008","volume":"426","author":"J Seifert","year":"2007","unstructured":"Seifert J, Ossege S, Emrich HM, Schneider U, Stuhrmann M . No association of CNR1 gene variations with susceptibility to schizophrenia. Neurosci Lett 2007; 426: 29\u201333.","journal-title":"Neurosci Lett"},{"key":"BFtpj200959_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.mp.4000247","volume":"2","author":"DE Comings","year":"1997","unstructured":"Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G et al. Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol Psychiatry 1997; 2: 161\u2013168.","journal-title":"Mol Psychiatry"},{"key":"BFtpj200959_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/sj.mp.4000670","volume":"5","author":"T Li","year":"2000","unstructured":"Li T, Liu X, Zhu ZH, Zhao J, Hu X, Ball DM et al. No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol Psychiatry 2000; 5: 128\u2013130.","journal-title":"Mol Psychiatry"},{"key":"BFtpj200959_CR29","volume-title":"Federal Regulation of Methadone Treatment. National Academy of Sciences","author":"RA Rettig","year":"1995","unstructured":"Rettig RA, Yarmolinsky A (eds) Federal Regulation of Methadone Treatment. National Academy of Sciences. National Academy Press: Washington, DC, 1995."},{"key":"BFtpj200959_CR30","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC 1994."},{"key":"BFtpj200959_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0376-8716(02)00308-3","volume":"69","author":"SH Kellogg","year":"2003","unstructured":"Kellogg SH, McHugh PF, Bell K, Schluger JH, Schluger RP, LaForge KS et al. The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend 2003; 69: 137\u2013150.","journal-title":"Drug Alcohol Depend"},{"key":"BFtpj200959_CR32","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","volume":"95","author":"C Bond","year":"1998","unstructured":"Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998; 95: 9608\u20139613.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj200959_CR33","doi-asserted-by":"crossref","DOI":"10.1201\/b15072","volume-title":"The Analysis of Contingency Tables","author":"BS Everitt","year":"1992","unstructured":"Everitt BS . The Analysis of Contingency Tables, 2nd edn. Chapman & Hall\/CRC: Boca Raton, FL, 1992."},{"key":"BFtpj200959_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/0471249688","volume-title":"Categorical Data Analysis","author":"A Agresti","year":"2002","unstructured":"Agresti A . Categorical Data Analysis, 2nd edn. Wiley-Interscience: Hoboken, NJ, 2002."},{"key":"BFtpj200959_CR35","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1101\/gr.204001","volume":"11","author":"J Hoh","year":"2001","unstructured":"Hoh J, Wille A, Ott J . Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res 2001; 11: 2115\u20132119.","journal-title":"Genome Res"},{"key":"BFtpj200959_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263\u2013265.","journal-title":"Bioinformatics"},{"key":"BFtpj200959_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/sj.tpj.6500352","volume":"6","author":"N Ballon","year":"2006","unstructured":"Ballon N, Leroy S, Roy C, Bourdel MC, Charles-Nicolas A, Krebs MO et al. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. Pharmacogenomics J 2006; 6: 126\u2013130.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj200959_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13556210020040271","volume":"6","author":"D Heller","year":"2001","unstructured":"Heller D, Schneider U, Seifert J, Cimander KF, Stuhrmann M . The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users. Addict Biol 2001; 6: 183\u2013187.","journal-title":"Addict Biol"},{"key":"BFtpj200959_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0376-8716(01)00164-8","volume":"65","author":"LG Schmidt","year":"2002","unstructured":"Schmidt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki J, Wendel B et al. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 2002; 65: 221\u2013224.","journal-title":"Drug Alcohol Depend"},{"key":"BFtpj200959_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00406-003-0440-7","volume":"253","author":"UW Preuss","year":"2003","unstructured":"Preuss UW, Koller G, Zill P, Bondy B, Soyka M . Alcoholism-related phenotypes and genetic variants of the CB1 receptor. Eur Arch Psychiatr Clin Neourosci 2003; 253: 275\u2013280.","journal-title":"Eur Arch Psychiatr Clin Neourosci"},{"key":"BFtpj200959_CR41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ajmg.10038","volume":"105","author":"S Leroy","year":"2001","unstructured":"Leroy S, Griffon N, Bourdel MC, Oli\u00e9 JP, Poirier MF, Krebs MO . Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. Am J Med Genet 2001; 105: 749\u2013752.","journal-title":"Am J Med Genet"},{"key":"BFtpj200959_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1192\/bjp.bp.107.036129","volume":"191","author":"S Zammit","year":"2007","unstructured":"Zammit S, Spurlock G, Williams H, Norton N, Williams N, O\u2019Donovan MC et al. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry 2007; 191: 402\u2013407.","journal-title":"Br J Psychiatry"},{"key":"BFtpj200959_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.euroneuro.2007.05.005","volume":"18","author":"N Hamdani","year":"2008","unstructured":"Hamdani N, Tabeze JP, Ramoz N, Ades J, Hamon M, Sarfati Y et al. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia. Eur Neuropsychopharmacol 2008; 18: 34\u201340.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtpj200959_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ajmg.b.30325","volume":"141B","author":"AI Herman","year":"2006","unstructured":"Herman AI, Kranzler HR, Cubells JF, Gelernter J, Covault J . Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 499\u2013503.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFtpj200959_CR45","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.biopsych.2006.12.004","volume":"62","author":"L Zuo","year":"2007","unstructured":"Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J . CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry 2007; 62: 616\u2013626.","journal-title":"Biol Psychiatry"},{"key":"BFtpj200959_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neulet.2004.11.050","volume":"376","author":"Y Morita","year":"2005","unstructured":"Morita Y, Ujike H, Tanaka Y, Uchida N, Nomura A, Ohtani K et al. A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia. Neurosci Lett 2005; 376: 182\u2013187.","journal-title":"Neurosci Lett"},{"key":"BFtpj200959_CR47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00439-006-0250-x","volume":"120","author":"JM Flanagan","year":"2006","unstructured":"Flanagan JM, Gerber AL, Cadet JL, Beutler E, Sipe JC . The fatty acid amide hydrolase 385 A\/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum Genet 2006; 120: 581\u2013588.","journal-title":"Hum Genet"},{"key":"BFtpj200959_CR48","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/ajmg.b.30491","volume":"144B","author":"RF Tyndale","year":"2007","unstructured":"Tyndale RF, Payne JI, Gerber AL, Sipe JC . The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in Caucasians. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 660\u2013666.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj200959.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj200959","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj200959.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:17:59Z","timestamp":1647944279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj200959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,15]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFtpj200959"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2009.59","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,15]]},"assertion":[{"value":"26 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}